Safety and efficacy of Pradaxa < sup > ® < /sup > (dabigatran etexilate) reconfirmed in clinical setting for VTE prevention after total knee or hip replacement

Safety and efficacy of Pradaxa < sup > ® < /sup > (dabigatran etexilate) reconfirmed in clinical setting for VTE prevention after total knee or hip replacement

Source: Boehringer Ingelheim Corporate News - July 25, 2016 Category: Research Source Type: news